In line with these observations, platinum-taxane chemotherapy positively interacted with an ICI targeting programmed cell death 1 (PDCD1, best known as PD1) in a syngeneic preclinical mouse model of ovarian cancer bearing high (but not low) tumor mutational burden. Here, PDCD1 is linked to neoplasm.